"También conocido como el 'Hospital del Conocimiento', el Hospital Universitario Dexeus es un centro de referencia en muchas de sus especialidades, siendo uno de los primeros centros privados universitarios de toda España. El Hospital Universitari Dexeus de Barcelona ofrece asistencia médica y quirúrgica de primer nivel en todas las especialidades, destacando entre ellas la Obstetricia y Ginecología, la Traumatología y la Pediatría. El centro cuenta con un sólido equipo de profesionales médicos e incorpora los últimos avances funcionales y tecnológicos propios de los centros de medicina más punteros."

During the past decade, Hospital Universitari Dexeus conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 25 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 17 clinical trials were completed. i.e. 30.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitari Dexeus" #1 sponsor was "Janssen Research & Development, LLC" with 9 trials, followed by "Spanish Lung Cancer Group" with 9 trials sponsored, "Fundación GECP" with 8 trials sponsored, "Institut Universitari Dexeus" with 8 trials sponsored and "Hoffmann-La Roche" with 8 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Dexeus" #1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari Dexeus" are "Infertility" (13 trials), "Carcinoma, Non-Small-Cell Lung" (9 trials), "Non-small Cell Lung Cancer" (8 trials), "Non Small Cell Lung Cancer" (5 trials) and "Non-Small Cell Lung Cancer" (5 trials). Many other conditions were trialed in "Hospital Universitari Dexeus" in a lesser frequency.

Most popular intervention types in "Hospital Universitari Dexeus" are "Drug" (97 trials), "Biological" (11 trials), "Other" (6 trials), "Diagnostic Test" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Carboplatin" (12 trials), "Pemetrexed" (8 trials), "Nivolumab" (7 trials) and "Amivantamab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari Dexeus" are 88 trials for "All" genders and 34 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitari Dexeus". 1 are not yet recruiting, 33 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Hospital Universitari Dexeus, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari Dexeus, 14 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 5 trials that are defined as “Not Applicable".